officialstreetpreachers Subscribe
Published: September 10, 2021

BioNTech seeks approval for infant COVID jabs by end of 2021, children age 5 and up this month

By The Editor
lifesite

Fri Sep 10, 2021 – 8:07 pm EDT

LifeSiteNews has produced an extensive COVID-19 vaccines resources page. View it here. 

(LifeSiteNews) — Infants as young as six months old may soon be eligible for the abortion-tainted COVID-19 shot if BioNTech receives approval for the jab it developed in collaboration with Pfizer. 

Just weeks after the Food and Drug Administration (FDA) approved the two-dose mRNA Pfizer/BioNTech shot for all Americans age 16 and up, the two top executives of German biotechnology company BioNTech announced that they are seeking approval of the drugs from global regulators for use in children age five and up in the next several weeks.  

This comes in spite of the fact that the Pfizer jab has still not been fully approved for children ages 12 to 15, for which it still maintains an Emergency Use Authorization (EUA). 

As reported by Reuters on Friday, “BioNTech has said it expected to file its regulatory dossier on the five- to 11-year-olds in September. It has also laid out plans to seek approval in children aged 6 months to two years later this year.” 

It is unclear why the three- to four-year-old age group appears to have been left out of the calculation. 

“Already over the next few weeks we

The remainder of this article is available in its entirety at LifeSite News

The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors


Share this Article

Download the Mobile App.
Exit mobile version